News

Dr. Lola Fayanju Receives NIH Award for Health Disparities Research

Lola Fayanju, MD, Assistant Professor of Surgery, Division of Surgical Oncology, recently received a K08 award from the National Institutes of Health for her proposal "Using Modifiable Risk Factors to Predict Inferior Care and Survival After Breast Cancer Diagnosis: A Novel Approach to Addressing Health Disparities." With this grant, Dr. Fayanju and her team will develop a prediction model to identify women with mutable risk factors for compromised breast cancer care, providing a novel approach to addressing disparities in oncologic care.

Three Duke Surgery Faculty Members Receive Distinguished Professorships

Three faculty members from the Duke Department of Surgery have received distinguished professorships from Duke University. Distinguished professorships are awarded to the most distinguished faculty who have demonstrated extraordinary scholarship in advancing science and improving human health.

Duke Surgery Holds 4th Annual Research Day

The Department of Surgery held its 4th Annual Research Day April 17. The department holds this event annually to advance its mission of improving patient care through research and training the next generation of surgeon–scientists. The event recognizes the accomplishments of fellows, residents, and students engaged in clinical or basic and translational research through the department.

Duke Surgery Ranks First Nationwide in NIH Funding

The Blue Ridge Institute for Medical Research has released its 2018 rankings of NIH funding for basic and clinical science departments, revealing that Duke Surgery ranks highest nationwide with more than $30 million in funding committed to research.

Dr. Rosenberger to Present at SSO Annual Cancer Symposium

Please join the department in congratulating Laura Horst Rosenberger, MD, Assistant Professor of Surgery in the Division of Surgical Oncology, whose abstract has been accepted by the Society of Surgical Oncology (SSO) for presentation at the 72nd Annual Cancer Symposium.

Dr. Rosenberger will present her abstract, “Axillary Lymph Node Dissection in Node-Positive Breast Cancer: Are 10-Nodes Adequate and When is Enough, Enough?” during the Breast Parallel Session of the symposium. Abstracts were reviewed and accepted by a blind peer-review program committee.  

Breast Cancer Patients Prefer Knowing Costs Prior to Starting Treatment

Even well-insured women experienced financial toxicity associated with cancer care

Even when they had good health insurance coverage, women with breast cancer reported having financial worries related to their care, and the vast majority said they preferred to know about treatment costs at the time of diagnosis.

The findings from a study by Duke Cancer Institute researchers highlight the importance of considering medical costs as women face breast cancer treatment decisions.